Enliven Therapeutics, Inc. (ELVN)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 5 signals for Enliven Therapeutics, Inc.. Most notable: 2026-06-22: ORBIMED ADVISORS LLC (ten_percent_owner) sold $35.7M of stock; 2026-08-04: Derynck Mika K (director) sold $9.6M of stock; 2026-06-22: ORBIMED ADVISORS LLC (ten_percent_owner) sold $2.1M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Large insider sale
    Derynck Mika K (director) sold $9.6M of stock
  2. Large insider sale
    ORBIMED ADVISORS LLC (ten_percent_owner) sold $35.7M of stock
  3. Large insider sale
    ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC (ten_percent_owner) sold $2.1M of stock
  4. Large insider sale
    ORBIMED ADVISORS LLC (ten_percent_owner) sold $2.1M of stock
  5. Large insider sale
    ORBIMED ADVISORS LLC (ten_percent_owner) sold $1.1M of stock
  6. Large insider sale
    ORBIMED ADVISORS LLC (ten_percent_owner) sold $12.3M of stock
  7. Material 8-K filing
    Filed 8-K disclosing material agreement
  8. Large insider sale
    Collins Helen Louise (officer) sold $1.4M of stock
  9. Large insider sale
    Collins Helen Louise (officer) sold $1.2M of stock
  10. Large insider sale
    Collins Helen Louise (officer) sold $1.2M of stock
  11. Large insider sale
    Patel Anish (officer) sold $1.3M of stock
  12. Large insider sale
    Lyssikatos Joseph P (officer) sold $1.5M of stock
  13. Large insider sale
    Patel Anish (officer) sold $1.3M of stock
  14. Large insider sale
    Lyssikatos Joseph P (officer) sold $1.0M of stock
  15. Material 8-K filing
    Filed 8-K disclosing director or officer change
  16. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-17Collins Helen LouiseofficerS24051.48$12,356
2026-09-17Collins Helen LouiseofficerS1,84450.71$93,507
2026-09-17Collins Helen LouiseofficerS2,91650.03$145,891
2026-09-17Collins Helen LouiseofficerM5,0002.48$12,400
2026-09-17Hohl BenjaminofficerS28951.49$14,881
2026-09-17Hohl BenjaminofficerS2,19450.72$111,270
2026-09-17Hohl BenjaminofficerS3,53550.03$176,851
2026-09-17Hohl BenjaminofficerM3,98214.85$59,133
2026-08-17Hohl BenjaminofficerS4,63058.35$270,168
2026-08-17Hohl BenjaminofficerS1,38859.35$82,383
2026-08-17Collins Helen LouiseofficerM5,0002.48$12,400
2026-08-17Collins Helen LouiseofficerS3,90058.37$227,650
2026-08-17Collins Helen LouiseofficerS1,10059.35$65,281
2026-08-04Derynck Mika KdirectorM87,3732.48$216,685
2026-08-04Derynck Mika KdirectorM27,56725.28$696,894
2026-08-04Derynck Mika KdirectorM23,36414.85$346,955
2026-08-04Derynck Mika KdirectorM20,49122.47$460,433
2026-08-04Derynck Mika KdirectorS158,79560.21$9,561,587
2026-07-17Hohl BenjaminofficerM1,0722.48$2,659
2026-07-17Hohl BenjaminofficerS32449.97$16,191
2026-07-17Hohl BenjaminofficerS36951.48$18,997
2026-07-17Hohl BenjaminofficerS2,56452.32$134,143
2026-07-17Hohl BenjaminofficerS2,63853.38$140,823
2026-07-17Hohl BenjaminofficerS12353.87$6,626
2026-07-17Collins Helen LouiseofficerM5,0002.48$12,400
2026-07-17Collins Helen LouiseofficerS23150.05$11,563
2026-07-17Collins Helen LouiseofficerS45951.55$23,660
2026-07-17Collins Helen LouiseofficerS2,06352.39$108,085
2026-07-17Collins Helen LouiseofficerS2,18453.42$116,669
2026-07-17Collins Helen LouiseofficerS6353.92$3,397
2026-07-06Kunkel Lori AnnedirectorS4,11149.98$205,482
2026-07-06Kunkel Lori AnnedirectorS5,88950.84$299,421
2026-06-22ORBIMED ADVISORS LLCten percent ownerS24,84645.38$1,127,511
2026-06-22ORBIMED ADVISORS LLCten percent ownerS46,77645$2,104,920
2026-06-22ORBIMED ADVISORS LLCten percent ownerS787,02445.38$35,715,149
2026-06-22ORBIMED ADVISORS LLCten percent ownerS1,47745$66,465
2026-06-22ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLCten percent ownerS24,84645.38$1,127,511
2026-06-22ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLCten percent ownerS1,47745$66,465
2026-06-22ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLCten percent ownerS787,02445.38$35,715,149
2026-06-22ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLCten percent ownerS46,77645$2,104,920
2026-06-17Hohl BenjaminofficerM6,0182.48$14,925
2026-06-17Hohl BenjaminofficerS1,23844.75$55,401
2026-06-17Hohl BenjaminofficerS3,40143.86$149,168
2026-06-17Hohl BenjaminofficerS1,37942.79$59,007
2026-06-17Collins Helen LouiseofficerM5,0002.48$12,400
2026-06-17Collins Helen LouiseofficerS1,26842.83$54,308
2026-06-17Collins Helen LouiseofficerS2,59943.87$114,018
2026-06-17Collins Helen LouiseofficerS1,13344.74$50,690
2026-06-17Hohl BenjaminofficerM6,0182.48$14,925
2026-06-17Hohl BenjaminofficerS1,37942.79$59,001

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings